10 CFR 26.133
§ 26.133 Cutoff levels for drugs and drug metabolites.
United States · 10 CFR — Energy · Status: effective
Cite this
- Citation
- 10 CFR 26.133, § 26.133 Cutoff levels for drugs and drug metabolites, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/36677
- Permanent ID
ys:prov:36677@1- SHA-256
a1e3f64714ae487f724c3d153962cda3b045938ccb1dfffaaa8ec003e749e518
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
Subject to the provisions of § 26.31(d)(3)(iii), licensees and other entities may specify more stringent cutoff levels for drugs and drug metabolites than those in Table 1 to § 26.133 and, in such cases, may report initial test results for only the more stringent cutoff levels. Otherwise, the following cutoff levels must be used for initial testing of urine specimens to determine whether they are negative or positive for the indicated drugs and drug metabolites:
Table 1 to § 26.133—Urine, Initial Test Cutoff Levels for Drugs and Drug Metabolites
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.